APA (7th ed.) Citation

H, C., YS, H., MC, K., TL, L., HW, K., HJ, S., . . . NC, C. (2026). β2-microglobulin is superior to lactate dehydrogenase and bulky disease for risk stratification in diffuse large B-cell lymphoma patients with IPI 1-2. Annals of hematology. https://doi.org/10.1007/s00277-026-07134-6

Chicago Style (17th ed.) Citation

H, Chang, Hung YS, Kuo MC, Lin TL, Kao HW, Shih HJ, Su YJ, Ong YC, and Chen NC. "β2-microglobulin Is Superior to Lactate Dehydrogenase and Bulky Disease for Risk Stratification in Diffuse Large B-cell Lymphoma Patients with IPI 1-2." Annals of Hematology 2026. https://doi.org/10.1007/s00277-026-07134-6.

MLA (9th ed.) Citation

H, Chang, et al. "β2-microglobulin Is Superior to Lactate Dehydrogenase and Bulky Disease for Risk Stratification in Diffuse Large B-cell Lymphoma Patients with IPI 1-2." Annals of Hematology, 2026, https://doi.org/10.1007/s00277-026-07134-6.